ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]

Gee, Julia Margaret Wendy, Harper, Maureen Elaine, Hutcheson, Iain Robert, Madden, Tracie-Ann, Barrow, Denise, Knowlden, Janice Mary, McClelland, Richard Andrew, Jordan, Nicola Jane, Wakeling, A. E. and Nicholson, Robert Ian 2002. ZD1839 ('Iressa') improves the antitumour activity of tamoxifen ('Nolvadex') and ICI 182, 780 ('Faslodex') in antihormone responsive breast cancer [Abstract]. European Journal of Cancer 38 (S7) , S59. 10.1016/S0959-8049(02)80835-8

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy Medicine
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Additional Information:	Abstract for Poster session Signal transduction modulators
Publisher:	Elsevier
ISSN:	0014-2964
Last Modified:	12 Jun 2019 02:10
URI:	http://orca.cf.ac.uk/id/eprint/17182

Citation Data

Cited 2 times in Google Scholar. View in Google Scholar

Actions (repository staff only)

Edit Item